What is Parkinson's Disease?
Parkinson's disease (PD) is a chronic, progressive neurodegenerative movement disorder characterized by the selective loss of dopaminergic neurons in the substantia nigra pars compacta, with accumulation of misfolded α-synuclein protein in intracytoplasmic inclusions called Lewy bodies. 1, 2
Core Pathophysiology
PD represents the most common neurodegenerative movement disorder, affecting over 6 million individuals worldwide 3. The disease involves:
- Neuronal loss: Profound degeneration of nigrostriatal dopaminergic neurons 4
- Protein aggregation: Accumulation of toxic α-synuclein in Lewy bodies, making PD both a cerebral amyloid disease and the most common synucleinopathy 5
- Molecular mechanisms: Mitochondrial dysfunction, oxidative damage, abnormal protein accumulation, and altered protein phosphorylation 4
Clinical Manifestations
Motor Symptoms (Cardinal Features)
The diagnosis requires bradykinesia plus at least one of the following 3, 2:
- Resting tremor (typically 4-6 Hz)
- Rigidity (increased muscle tone)
- Postural instability (balance impairment)
- Gait difficulty
Non-Motor Symptoms
These often precede motor symptoms and include 3, 6:
- Prodromal features: REM sleep behavior disorder, hyposmia (reduced sense of smell), constipation
- Neuropsychiatric: Depression, anxiety, cognitive decline, psychosis
- Autonomic dysfunction: Orthostatic hypotension, urinary problems, sexual dysfunction
- Sleep disorders: Insomnia, excessive daytime sleepiness
- Pain syndromes
Disease Heterogeneity
PD is not a uniform entity but encompasses multiple disease variants with different prognoses 3:
- Mild motor-predominant subtype (49-53% of patients): Mild symptoms, good response to dopaminergic medications, slower progression
- Diffuse malignant subtype (9-16% of patients): Prominent early motor and non-motor symptoms, poor medication response, faster progression
- Intermediate subtype: Between the two extremes
Etiology
Sporadic vs. Familial Forms
- Sporadic PD: Accounts for 85-95% of cases; etiology involves genetic susceptibilities combined with environmental factors 2, 4
- Familial PD: Accounts for 5-15% of cases; linked to specific genes including α-synuclein, parkin, DJ-1, PINK-1, and LRRK2 2, 4
The German Society of Neurology now endorses a broader concept of PD that incorporates both idiopathic and hereditary forms, moving away from the previously narrower "idiopathic Parkinson syndrome" terminology 7.
Epidemiology
- Prevalence: Approximately 108-257 per 100,000 in Europe 2
- Incidence: 11-19 per 100,000 per year 2
- Risk factors: Advanced age, male gender, specific environmental exposures 2
Diagnostic Approach
Diagnosis is principally clinical, based on history and neurological examination 3, 2. The German Society of Neurology recommends using the 2015 Movement Disorders Society diagnostic criteria 7.
When Imaging is Helpful
Dopamine transporter single-photon emission computed tomography (DAT-SPECT) can improve diagnostic accuracy when the presence of parkinsonism is uncertain 3. This helps differentiate PD from other conditions that may mimic it.
Importance of Follow-up
Long-term clinical follow-up significantly improves diagnostic accuracy, as the disease pattern becomes clearer over time 7.
Evolving Diagnostic Paradigm
A major shift toward biological definition is being advocated, similar to Alzheimer's and Huntington's diseases, with the goal of earlier detection before cardinal motor symptoms appear 1. This approach incorporates:
- In vivo detection of neuronal α-synuclein aggregation
- Markers of neurodegeneration
- Genetic testing
- Biomarker assessment
This represents a fundamental change from purely clinical motor-based diagnosis to one that can identify disease in presymptomatic stages, potentially enabling earlier disease-modifying interventions 1.